Home » Newsletters » BioWorld Science

BioWorld Science

May 28, 2001

View Archived Issues

Connetics makes changes to focus on dermatology business

Suppression of cold I/R injury in liver transplantation using p38 MAP kinase inhibitor

Similar reductions in cytokine production seen in monkeys treated with A-285222 or ciclosporin

Novel TNF-alpha inhibitor prevents liver failure, promotes liver regeneration following HTx

Endovasc provides Q1 2001 update

Small-molecule inhibitor of IKK complex prevents acute cardiac allograft rejection

Clinical trial demonstrates high response rate to infliximab in psoriasis

Interneuron reports product update

ATS 2001: JNK inhibitors as next-generation compounds for asthma

Xanelim shows promise in treatment of moderate to severe psoriasis

Efficacy and safety of inhaled insulin maintained over two years in diabetic patients

Company Profile: EpiGenX

GlaxoSmithKline's HIV vaccine candidate shows promise in preclinical trials

Potentially orally active, potent steroidal androgens designed at Organon

Xyrem provides overall improvement in narcolepsy patients

Potent, selective, second-generation PDE4 inhibitor with improved safety profile

Antiischemic agents from SCRAS act on mitochondria

Investigational anticancer agent phenoxodiol enters first U.S. trial

Company Profile: CoPharma

Bisphosphonic acid derivatives and use in treatment, diagnosis of bone diseases

New osteoclast vacuolar H+-ATPase inhibitors in the AstraZeneca portfolio

NK-30424 analogues useful as antitumor and antiinflammatory agents

Squalene synthase inhibitors designed at Eisai inhibit cholesterol biosynthesis

Novel diazepanes inhibit interaction of LFA-1 with ICAMs

Cytokine-inhibitory pyrimidines under evaluation at AstraZeneca

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...